MAUREEN KLEMME: Open Payments
NPI 1194821553 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 59 payments from 16 companies in 2025. Trend: 2023 $2,127 · 2024 $1,093 · 2025 $1,542
Food & beverage: $1,529Education: $12
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $445 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $159 |
| Xeris Pharmaceuticals, Inc. | 11 | $155 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| Dexcom, Inc. | 4 | $95 |
| ABBVIE INC. | 4 | $74 |
| Corcept Therapeutics | 3 | $52 |
| Lilly USA, LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Ozempic, Kerendia, CAPLYTA, Auvelity, Wegovy, RECORLEV, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across IL — which companies pay providers there.
